CYCLERION THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
CYCLERION THERAPEUTICS, INC. (CYCN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 43.42 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-04
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 43.42M shares, a 27.42% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 43.39M shares, a 27.52% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 43.29M shares, a 34.88% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 35.71M shares, a 28.48% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 39.14M shares, a 28.75% increase from fiscal 2020.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 30.40M shares, a 11.04% increase from fiscal 2019.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 27.38M shares, a 99900.00% increase from fiscal 2018.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 27.38K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 43.42M shares 10-Q · filed 2022-05-04 | 43.41M shares derived: average of 2 quarters · filed 2022-05-04 | 43.37M shares derived: average of 3 quarters · filed 2022-05-04 | 41.45M shares derived: average of 4 quarters · filed 2022-05-04 | ||||
| 2021-12-31 | 43.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 43.34M shares derived: average of 2 quarters · filed 2022-02-24 | 40.79M shares derived: average of 3 quarters · filed 2022-02-24 | 39.14M shares 10-K · filed 2022-02-24 | ||||
| 2021-09-30 | 43.29M shares 10-Q · filed 2021-11-09 | 39.50M shares derived: average of 2 quarters · filed 2021-11-09 | 37.73M shares 10-Q · filed 2021-11-09 | 36.78M shares derived: average of 4 quarters · filed 2022-05-04 | ||||
| 2021-06-30 | 35.71M shares 10-Q · filed 2021-07-29 | 34.90M shares 10-Q · filed 2021-07-29 | 34.60M shares derived: average of 3 quarters · filed 2022-05-04 | 33.98M shares derived: average of 4 quarters · filed 2022-05-04 | ||||
| 2021-03-31 | 34.08M shares 10-Q · filed 2022-05-04 | 34.05M shares derived: average of 2 quarters · filed 2022-05-04 | 33.40M shares derived: average of 3 quarters · filed 2022-05-04 | 32.00M shares derived: average of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | 34.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 33.06M shares derived: average of 2 quarters · filed 2022-02-24 | 31.30M shares derived: average of 3 quarters · filed 2022-02-24 | 30.40M shares 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | 32.10M shares 10-Q · filed 2021-11-09 | 29.94M shares derived: average of 2 quarters · filed 2021-11-09 | 29.20M shares 10-Q · filed 2021-11-09 | 28.73M shares derived: average of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | 27.79M shares 10-Q · filed 2021-07-29 | 27.73M shares 10-Q · filed 2021-07-29 | 27.61M shares derived: average of 3 quarters · filed 2021-07-29 | 27.57M shares derived: average of 4 quarters · filed 2021-07-29 | ||||
| 2020-03-31 | 27.67M shares 10-Q · filed 2021-04-30 | 27.67K shares 10-Q · filed 2020-05-04 | 27.52M shares derived: average of 2 quarters · filed 2021-04-30 | 27.49M shares derived: average of 3 quarters · filed 2021-04-30 | 27.47M shares derived: average of 4 quarters · filed 2021-04-30 | |||
| 2019-12-31 | 27.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 27.41M shares derived: average of 2 quarters · filed 2021-02-25 | 27.40M shares derived: average of 3 quarters · filed 2021-02-25 | 27.38M shares 10-K · filed 2021-02-25 | 27.38K shares 10-K · filed 2020-03-12 | |||
| 2019-09-30 | 27.43M shares 10-Q · filed 2020-11-05 | 27.43K shares 10-Q · filed 2019-11-12 | 27.41M shares derived: average of 2 quarters · filed 2020-11-05 | 27.38M shares 10-Q · filed 2020-11-05 | 27.38K shares 10-Q · filed 2019-11-12 | 13.72M shares derived: average of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | 27.39M shares 10-Q · filed 2020-08-03 | 27.39K shares 10-Q · filed 2019-08-12 | 27.38M shares 10-Q · filed 2020-08-03 | 27.38K shares 10-Q · filed 2019-08-12 | 9.15M shares derived: average of 3 quarters · filed 2020-08-03 | 6.87M shares derived: average of 4 quarters · filed 2020-08-03 | ||
| 2019-03-31 | 27.38K shares 10-Q · filed 2020-05-04 | 27.38K shares derived: average of 2 quarters · filed 2020-05-04 | 27.38K shares derived: average of 3 quarters · filed 2020-05-04 | 27.38K shares derived: average of 4 quarters · filed 2020-05-04 | ||||
| 2018-12-31 | 27.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 27.38K shares derived: average of 2 quarters · filed 2020-03-12 | 27.38K shares derived: average of 3 quarters · filed 2020-03-12 | 27.38K shares 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | 27.38K shares 10-Q · filed 2019-11-12 | 27.38K shares derived: average of 2 quarters · filed 2019-11-12 | 27.38K shares 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | 27.38K shares 10-Q · filed 2019-08-12 | 27.38K shares 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |